Australia's largest stock trading and investment forum Australia's #1 stock forum

EPN

Click for more information

0.00%

2.4¢ epsilon healthcare limited

I was reading in the report that there is still some regulatory...

First 6 Last

Share
Profile

Follow
SPartner

200 Posts.

32

27/04/21

10:51

Post #: 52744594
Share

Originally posted by donkeyface: ↑

The numbers don't lie. We only have $4.6m left, which would only last about 2 more quarters. The fact that no actual production data released for the Southport facility, i.e. NO production whatsoever for all we can assume, and therefore no substantial revenue is forecasted any time soon. This is the biggest problem! Not the no CEO or whatever. Ultimately, the management failed to get actual orders and has no way to fulfil the orders, even if they did get some.

Remember we are a manufacturing company now(at least after the 'new strategy'), not some high tech, biomedical, shot for the moon company anymore. It is like saying we are a coffee shop, except we have no way of making a coffee.

So cap raise seems inevitable within the next few months.

Expand

I was reading in the report that there is still some regulatory licensing reqt for volume production lines - which means no surprise that purchase orders would be indicative and conditional on achieving license and therefore not disclosed in report. Maybe?

EPN Price at posting: 19.5¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

NIM

Nimy extends sulphide targets at Mons with new anomalies identified

NXM

Drilling at Bethanga shows signs of Cu-Au porphyry system for Nexus

SFX

Sheffield Resources achieves milestone production, shipments at Thunderbird, WA

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

There are more pages in this discussion • 8 more messages in this thread...

First 6 Last

Add EPN (ASX) to my watchlist